These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33682392)

  • 1. [Pharma industry reinvents itself in the turmoil. Part 1. Challenges].
    Coucke PA
    Rev Med Liege; 2021 Mar; 76(3):216-220. PubMed ID: 33682392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence for Pharma: Time for Internal Investment.
    Henstock PV
    Trends Pharmacol Sci; 2019 Aug; 40(8):543-546. PubMed ID: 31204059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharma industry reinvents itself in the turmoil. Part 2. Opportunities].
    Coucke PA
    Rev Med Liege; 2021 Apr; 76(4):292-296. PubMed ID: 33830695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The upside of being a digital pharma player.
    Schuhmacher A; Gatto A; Hinder M; Kuss M; Gassmann O
    Drug Discov Today; 2020 Sep; 25(9):1569-1574. PubMed ID: 32554063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digitizing the Pharma Neurons - A Technological Operation in Progress!
    Bhardwaj P; Yadav RK; Kurian S
    Rev Recent Clin Trials; 2020; 15(3):178-187. PubMed ID: 32564760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive study on Industry 4.0 in the pharmaceutical industry for sustainable development.
    Sharma D; Patel P; Shah M
    Environ Sci Pollut Res Int; 2023 Aug; 30(39):90088-90098. PubMed ID: 37129827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leading a Digital Transformation in the Pharmaceutical Industry: Reimagining the Way We Work in Global Drug Development.
    Finelli LA; Narasimhan V
    Clin Pharmacol Ther; 2020 Oct; 108(4):756-761. PubMed ID: 32294230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refinery 4.0, a Review of the Main Challenges of the Industry 4.0 Paradigm in Oil & Gas Downstream.
    Olaizola IG; Quartulli M; Unzueta E; Goicolea JI; Flórez J
    Sensors (Basel); 2022 Nov; 22(23):. PubMed ID: 36501863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strengthening pharma's contract with society: the value of trusted partnerships between pharma and healthcare facilitated by real-world data.
    Seewald MJ; Plumb JM; Gutierrez B; Liwing J; Tepie MF; Hammer M; LoCasale R; Khosla S; Yin D; Pashos CL; Nagy M
    J Comp Eff Res; 2020 Feb; 9(3):155-159. PubMed ID: 31964167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patentability challenges associated with emerging pharmaceutical technologies.
    Aggarwal S; Chandra A
    Pharm Pat Anal; 2021 Jul; 10(4):195-207. PubMed ID: 34253027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Industry 4.0 Concept to Health Care.
    Lhotska L
    Stud Health Technol Inform; 2020 Sep; 273():23-37. PubMed ID: 33087590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
    Janero DR
    Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The production and R&D structure of the Brazilian pharmaceutical industry: the role of public procurement and public drug production.
    Sorte Junior WF
    Glob Public Health; 2012; 7(10):1062-79. PubMed ID: 22950510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth of Industry 5.0: Making Sense of Big Data with Artificial Intelligence, "The Internet of Things" and Next-Generation Technology Policy.
    Özdemir V; Hekim N
    OMICS; 2018 Jan; 22(1):65-76. PubMed ID: 29293405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence in drug development: present status and future prospects.
    Mak KK; Pichika MR
    Drug Discov Today; 2019 Mar; 24(3):773-780. PubMed ID: 30472429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How academic labs can approach the drug discovery process as a way to synergize with big pharma.
    Loregian A; Palù G
    Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to compete with Google and Co.: big data and artificial intelligence in stones.
    Schoenthaler M; Boeker M; Horki P
    Curr Opin Urol; 2019 Mar; 29(2):135-142. PubMed ID: 30531434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.